OncXerna Therapeutics Company
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
Total Funding:
96500000
Headquarters:
Waltham, Massachusetts, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Last Funding Type:
Series B
Founded Date:
2018-01-01
Industry:
Gene therapy